AAK launches new skin care ingredient
The company said the formulation will be platformed at in-cosmetics event, to be held in Barcelona, Spain next month, according to cosmeticsdesign-europe.com. AAK’s new ingredient is used in
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.